Corticosteroid Therapy

  • Johanna C. Escher


Ulcerative Colitis Enteral Nutrition Crohn Disease Budesonide Group Moon Face 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn disease. Gastroenterology 2000;119(4):895–902.PubMedCrossRefGoogle Scholar
  2. 2.
    Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 2003;139(5 Pt 1): 359–70.Google Scholar
  3. 3.
    Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids–new mechanisms for old drugs. N Engl J Med 2005;353(16):1711–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn disease in children. J Pediatr Gastroenterol Nutr 2000;31(1):8–15.CrossRefGoogle Scholar
  5. 5.
    Beattie RM, Nicholls SW, Domizio P, Williams CB, Walker-Smith JA. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1996;22(4):373–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, et al. European evidence based consensus on the diagnosis and management of Crohn disease: current management. Gut 2006;55(Suppl 1):16–35.CrossRefGoogle Scholar
  7. 7.
    Markowitz J, Hyams J, Mack D, Leleiko N, Evans J, Kugathasan S, et al. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn disease. Clin Gastroenterol Hepatol 2006;4(9):1124–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros A, et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006;4(9):1118–23.PubMedCrossRefGoogle Scholar
  9. 9.
    Faubion WA, Jr., Loftus EV, Jr., Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121(2):255–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006;24(2):319–30.PubMedCrossRefGoogle Scholar
  11. 11.
    Dilger K, Alberer M, Busch A, Enninger A, Behrens R, Koletzko S, et al. Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn disease. Aliment Pharmacol Ther 2006;23(3):387–96.PubMedCrossRefGoogle Scholar
  12. 12.
    Lundin PD, Edsbacker S, Bergstrand M, Ejderhamn J, Linander H, Hogberg L, et al. Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn disease. Aliment Pharmacol Ther 2003;17(1):85–92.PubMedCrossRefGoogle Scholar
  13. 13.
    Levine A, Weizman Z, Broide E, Shamir R, Shaoul R, Pacht A, et al. A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2003;36(2):248–52.PubMedCrossRefGoogle Scholar
  14. 14.
    Escher JC. Budesonide versus prednisolone for the treatment of active Crohn disease in children: a randomized, double-blind, controlled, multicentre trial. Eur J Gastroenterol Hepatol 2004;16(1):47–54.PubMedCrossRefGoogle Scholar
  15. 15.
    Levine A, Broide E, Stein M, Bujanover Y, Weizman Z, Dinari G, et al. Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn disease in children. J Pediatr 2002;140(1):75–80.PubMedCrossRefGoogle Scholar
  16. 16.
    Otley A, Steinhart AH. Budesonide for induction of remission in Crohn disease. Cochrane Database Syst Rev 2005(4):CD000296.Google Scholar
  17. 17.
    Rutgeerts P, Lofberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budesonide with prednisolone for active Crohn disease. N Engl J Med 1994;331(13):842–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Bar-Meir S, Chowers Y, Lavy A, Abramovitch D, Sternberg A, Leichtmann G, et al. Budesonide versus prednisone in the treatment of active Crohn disease. The Israeli Budesonide Study Group. Gastroenterology 1998;115(4):835–40.PubMedCrossRefGoogle Scholar
  19. 19.
    Gross V, Andus T, Ecker KW, Raedler A, Loeschke K, Plauth M, et al. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn disease. The Budesonide Study Group. Gut 1998;42(4):493–6.PubMedGoogle Scholar
  20. 20.
    Campieri M, Ferguson A, Doe W, Persson T, Nilsson LG. Oral budesonide is as effective as oral prednisolone in active Crohn disease. The Global Budesonide Study Group. Gut 1997;41(2):209–14.PubMedCrossRefGoogle Scholar
  21. 21.
    Levine A, Watemberg N, Hager H, Bujanover Y, Ballin A, Lerman-Sagie T. Benign intracranial hypertension associated with budesonide treatment in children with Crohn disease. J Child Neurol 2001;16(6):458–61.PubMedCrossRefGoogle Scholar
  22. 22.
    Kundhal P, Zachos M, Holmes JL, Griffiths AM. Controlled ileal release budesonide in pediatric Crohn disease: efficacy and effect on growth. J Pediatr Gastroenterol Nutr 2001;33(1):75–80.PubMedCrossRefGoogle Scholar
  23. 23.
    Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Williams CN, et al. Oral budesonide as maintenance treatment for Crohn disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 1996;110(1):45–51.PubMedCrossRefGoogle Scholar
  24. 24.
    Lofberg R, Rutgeerts P, Malchow H, Lamers C, Danielsson A, Olaison G, et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn disease. A placebo controlled one year study. Gut 1996;39(1):82–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Ferguson A, Campieri M, Doe W, Persson T, Nygard G. Oral budesonide as maintenance therapy in Crohn disease–results of a 12-month study. Global Budesonide Study Group. Aliment Pharmacol Ther 1998;12(2):175–83.PubMedCrossRefGoogle Scholar
  26. 26.
    Simms L, Steinhart AH. Budesonide for maintenance of remission in Crohn disease. Cochrane Database Syst Rev 2001(1):CD002913.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Johanna C. Escher
    • 1
  1. 1.Department of Pediatric GastroenterologyErasmus MC-Sophia Children’s Hospital, University Medical CenterThe Netherlands

Personalised recommendations